Global private equity and venture capital news and research

Posts Tagged ‘Novartis’

30 June 2015

Spinifex investors to exit as Novartis agrees to $200m-plus buyout

health healthcare drugs pills medication medical Novo A/S, Canaan Partners, GBS Venture Partners, Brandon Capital Partners, Uniseed and the University of Queensland will shortly exit their investments in Spinifex Pharmaceuticals, as Novartis International AG has agreed to buy it for $200m cash, "plus undisclosed clinical development and regulatory milestone payments".

24 November 2014

Legend, Novartis lead $53m round in BioNano Genomics

syringe-m Legend Capital and Novartis Venture Fund have led a $53m Series C financing round in genome mapping company BioNano Genomics.

3 June 2014

Proteus Digital Health snags $120m

medical monitor Private equity-backed digital medicines company Proteus Digital Health has secured a $120m investment.

11 November 2013

VC-backed GlycoMimetics postpones $64m-targeting IPO

Venture capital-backed biotech company GlycoMimetics has reportedly postponed its IPO, which was supposed to launch last Friday targeting up to $64m.

28 October 2013

GlycoMimetics aims to raise up to $64m via IPO

biotech_lrg Venture capital-backed biotech company GlycoMimetics plans to float 4m shares worth as much as $64m in an IPO on the Nasdaq exchange.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015